Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 2, 2014, Pages 568-571

  Gasch, O ^a,o   Camoez, M ^a,o   Dominguez M A ^a,o   Padilla, B ^b   Pintado, V ^c   Almirante, B ^d,d   Martin C ^e   Lopez Medrano F ^f,f   De gopegui, E Ruiz ^g   Blanco, J R ^h   Garcia Pardo G ⁱ   Calbo, E ^j   Montero, M ^k,k   Granados, A ^l,l   Jover, A ^m   Duenas C ⁿ   Pujol, M ^a   Barcenilla, F ^m   Garcia M ^m   Ojeda, E ⁿ   Martinez J A ^p   Marco, F ^p   Chaves, F ^f   Lagarde, M ^f   Montejo, J M ^q   Bereciertua, E ^q   Hernandez J L ^q   von Wichmann, M A ^r   Goenaga, A ^r   Garcia Arenzana J M ^r   Padilla, C ^b   Cercenado, E ^b   Garcia Prado G ⁱ   Tapiol, J ⁱ   Horcajada, J P ^k   Salvado M ^k   Arnaiz A ^s   Fernandez C ^s   Xercavins, M ^j   Fontanals, D ^l   Loza, E ^c   Torre Cisneros, J ^t   Lara, R ^t   Rodriguez Lopez F ^t   Rodriguez M ^t   Natera, C ^t   Olarte, I ^h   Benito, N ^u   Mirelis, B ^u   Murillas, J ^g   Ruiz de Gopegui, E ^g   Espejo, H ^v   Morera, M A ^v   Rodriguez Bano J ^w   Lopez Cortes L E ^w   Pascual, A ^w   Lepe, J A ^e   Molina, J ^e   Sorde R ^d   Larrosa, N ^d   more..

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^f HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^g HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^h HOSPITAL SAN PEDRO   (Spain)

ⁱ HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^j HOSPITAL MÚTUA DE TERRASSA   (Spain)

^k HOSPITAL DEL MAR   (Spain)

^l Servicio de Cirugía General Y Aparato Digestivo   (Spain)

^m HOSPITAL ARNAU DE VILANOVA   (Spain)

ⁿ HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

^o UNIVERSITY OF BARCELONA   (Spain)

^p HOSPITAL CLÍNIC   (Spain)

^q HOSPITAL DE CRUCES   (Spain)

^r HOSPITAL DONOSTIA   (Spain)

^s HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^t HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^u HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^v HOSPITAL DE TERRASSA   (Spain)

^w HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

more..

Author keywords

Bloodstream infections; Cationic peptides; MICs; Outcomes

Indexed keywords

DAPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOOD CULTURE; DRUG MONITORING; DRUG TREATMENT FAILURE; ENDOCARDITIS; FOLLOW UP; HUMAN; INFORMED CONSENT; LETTER; MEDICAL SPECIALIST; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; OSTEOMYELITIS;

BLOODSTREAM INFECTIONS; CATIONIC PEPTIDES; MICS; OUTCOMES;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; COHORT STUDIES; DAPTOMYCIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 84892461171     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt396     Document Type: Letter

References (8)

1. Moore CL, Osaki-Kiyan P, Haque NZ et al. Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study. Clin Infect Dis 2012; 54: 51-8.
2. Falagas ME, Giannopoulou KP, NtzioraFet al. Daptomycin forendocarditis and/or bacteraemia: a systematic review of the experimental and clinical evidence. J Antimicrob Chemother 2007; 60: 7-19.
3. Moise PA, North D, Steenbergen JN et al. Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions. Lancet Infect Dis 2009; 9: 617-24.
4. Liu C, Bayer A, Cosgrove SE et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillinresistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52: e18-55.
5. Gasch O, Camoez M, Domínguez MA et al. Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 2013; 68: 1423-30.
6. Bayer AS, Schneider T, Sahl HG. Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cellmembraneandcellwall. AnnNYAcad Sci 2013; 1277: 139-58.
7. Fowler VG Jr, Boucher HW, Corey GR et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006; 355: 653-65.
8. Sharma M, Riederer K, Chase P et al. High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 2008; 27: 433-7.